Abstract

Total parenteral nutrition is a medication used to manage and treat malnourishment. It is in the nutrition class of drugs. Parenteral nutrition (TPN) is when the intravenous administered nutrition can serve as the main source of nutrition and also as a supplementary nutrition if the patient is not having adequate nutrition. This article highlights the composition, initiation, indications, contraindications, complications of total parenteral nutrition as a valuable agent in managing malnourishment.

• 1.   Compher C, Bingham AL, McCall M, et al. Guidelines for the provision of nutritionsupport therapy in the adult critically ill patient: The American Society for Parenteral andEnteral Nutrition. JPEN J Parenter Enteral Nutr 2022; 46:12.
• 2.   Kuwahara T, Asanami S, Tamura T, Kaneda S. Effects of pH and osmolality on phlebiticpotential of infusion solutions for peripheral parenteral nutrition. J ToxicolSci 1998;23:77.
• 3.   Kuwahara T, Asanami S, Tamura T, Kubo S. Dilution is effective in reducing infusionphlebitis in peripheral parenteral nutrition: an experimental study in rabbits. Nutrition1998; 14:186.
• 4.   Kovacevich DS, Corrigan M, Ross VM, et al. American Society for Parenteral and EnteralNutrition Guidelines for the Selection and Care of Central Venous Access Devices forAdult Home Parenteral Nutrition Administration. JPEN J Parenter Enteral Nutr 2019;43:15.
• 5.   Safdar N, Kluger DM, Maki DG. A review of risk factors for catheter related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine (Baltimore) 2002; 81:466.
• 6.   Hon K, Bihari S, Holt A, et al. Rate of Catheter-Related Bloodstream Infections BetweenTunneled Central Venous Catheters Versus Peripherally Inserted Central Catheters inAdult Home Parenteral Nutrition: A Meta-analysis. JPEN J Parenter Enteral Nutr 2019;43:41.
• 7.   Cotogni P, Pittiruti M, Barbero C, et al. Catheterrelated complications in cancer patientson home parenteral nutrition: a prospective study of over 51,000 catheter days. JPEN JParenter Enteral Nutr 2013; 37:375.
• 8.   Buchman AL, Opilla M, Kwasny M, et al. Risk factors for the development of catheter-related bloodstream infections in patients receiving home parenteral nutrition. JPEN JParenter Enteral Nutr 2014; 38:744.
• 9.   Bech LF, Drustrup L, Nygaard L, et al. Environmental Risk Factors for DevelopingCatheter-Related Bloodstream Infection in Home Parenteral Nutrition Patients: A 6-YearFollow-up Study. JPEN J Parenter Enteral Nutr 2016; 40:989.
• 10.   O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention ofintravascular catheter-related infections. Centers for Disease Control and Prevention.MMWRRecomm Rep 2002; 51:1.
• 11.   Mirtallo J, Canada T, Johnson D, et al. Safe practices for parenteral nutrition. JPEN JParenter Enteral Nutr 2004; 28:S39.
• 12.   Naylor CJ, Griffiths RD, Fernandez RS. Does a multidisciplinary total parenteral nutritionteam improve patient outcomes? A systematic review. JPEN J Parenter Enteral Nutr 2004;28:251.
• 13.   Ayers P, Adams S, Boullata J, et al. A.S.P.E.N. parenteral nutrition safety consensusrecommendations. JPEN J Parenter Enteral Nutr 2014; 38:296.
• 14.   Boullata JI, Gilbert K, Sacks G, et al. A.S.P.E.N. clinical guidelines: parenteral nutritionordering, order review, compounding, labeling, and dispensing. JPEN J ParenterEnteralNutr 2014; 38:334.
• 15.   Guenter P, Boullata JI, Ayers P, et al. Standardized Competencies for Parenteral NutritionPrescribing: The American Society for Parenteral and Enteral Nutrition Model. NutrClinPract 2015; 30:570.
• 16.   Slattery E, Rumore MM, Douglas JS, Seres DS. 3-in-1 vs 2-in-1 parenteral nutrition inadults: a review. NutrClinPract 2014; 29:631.
• 17.   Manzanares W, Dhaliwal R, Jurewitsch B, et al. Parenteral fish oil lipid emulsions in thecritically ill: a systematic review and meta-analysis. JPEN J Parenter Enteral Nutr 2014;38:20.
• 18.   Edmunds CE, Brody RA, Parrott JS, et al. The effects of different IV fat emulsions onclinical outcomes in critically ill patients. Crit Care Med 2014; 42:1168.
• 19.   Hall TC, Bilku DK, Al-Leswas D, et al. A randomized controlled trial investigating theeffects of parenteral fish oil on survival outcomes in critically ill patients with sepsis: apilot study. JPEN J Parenter Enteral Nutr 2015; 39:301.
• 20.   Abbasoglu O, Hardy G, Manzanares W, PontesArruda A. Fish Oil-Containing LipidEmulsions in Adult Parenteral Nutrition: A Review of the Evidence. JPEN J ParenterEnteralNutr 2019; 43:458.
• 21.   Pradelli L, Mayer K, Klek S, et al. ω-3 Fatty-Acid Enriched Parenteral Nutrition inHospitalized Patients: Systematic Review With MetaAnalysis and Trial SequentialAnalysis. JPEN J Parenter Enteral Nutr 2020; 44:44.
• 22.   Mirtallo JM, Ayers P, Boullata J, et al. ASPEN Lipid Injectable Emulsion SafetyRecommendations, Part 1: Background and Adult Considerations. NutrClinPract 2020;35:769.
• 23.   Zhang YP, Wan YD, Sun TW, et al. Association between vitamin D deficiency andmortality in critically ill adult patients: a meta-analysis of cohort studies. Crit Care 2014;18:684.
• 24.   Amrein K, Schnedl C, Holl A, et al. Effect of high-dose vitamin D3 on hospital length ofstay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinicaltrial. JAMA 2014; 312:1520.
• 25.   Heyland DK, Dhaliwal R, Drover JW, et al. Canadian clinical practice guidelines fornutrition support in mechanically ventilated, critically ill adult patients. JPEN J ParenterEnteralNutr 2003; 27:355.
• 26.   Grau T, Bonet A, Miñambres E, et al. The effect of L-alanyl-L-glutamine dipeptidesupplemented total parenteral nutrition on infectious morbidity and insulin sensitivity incritically ill patients. Crit Care Med 2011; 39:1263.
• 27.   Heyland D, Muscedere J, Wischmeyer PE, et al. A randomized trial of glutamine andantioxidants in critically ill patients. N Engl J Med 2013; 368:1489.
• 28.   Jones JS, Tidwell B, Travis J, et al. Nutritional support of the hospitalized patient: a teamapproach. J Miss State Med Assoc 1995; 36:91.
• 29.   Fonseca G, Burgermaster M, Larson E, Seres DS. The Relationship Between ParenteralNutrition and Central Line-Associated Bloodstream Infections. JPEN J ParenterEnteralNutr 2017; :148607116688437.
• 30.   Yilmaz G, Koksal I, Aydin K, et al. Risk factors of catheter-related bloodstream infectionsin parenteral nutrition catheterization. JPEN J Parenter Enteral Nutr 2007; 31:284.
• 31.   da Silva JSV, Seres DS, Sabino K, et al. ASPEN Consensus Recommendations forRefeeding Syndrome. NutrClinPract 2020; 35:178.
• 32.   Mattioli S, Miglioli M, Montagna P, et al. Wernicke's encephalopathy during totalparenteral nutrition: observation in one case. JPEN J Parenter Enteral Nutr 1988; 12:626.
• 33.   Petrov MS, Zagainov VE. Influence of enteral versus parenteral nutrition on bloodglucose control in acute pancreatitis: a systematic review. ClinNutr 2007; 26:514.
• 34.   Mehanna HM, Moledina J, Travis J. Refeeding syndrome: what it is, and how to preventand treat it. BMJ 2008; 336:1495.

Data Sharing Statement

Funding